← SynDRA
CLOXACILLIN
SynDRA canonical compound SYN0002435 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | gram-positive bacterial infections |
| Disease area | infectious disease |
All known targets
- PBP2
- bla
- bla LAT-2
- blaACC-4
- blaT-3
- blaT-4
- mecA
- pbp4
- pbpA
- pbpF
- sugE
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- pbp4 INHIBITOR
- mecA INHIBITOR
- pbpA INHIBITOR
- PBP2 INHIBITOR
- pbpF INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- NR3C1
- NPY2R
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- GLS
- NR1I2
- OPRD1
- FYN
- OPRK1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01C · BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Cross-references
Synonyms
- CLOXACILLIN SODIUM
- CLOXAPEN
- Dry Clox
- TEGOPEN
- Methocillin S
- cloxacillin sodium
- cloxacillin sodium salt
- cloxacillin benzathine
- Cloxacilline
- Cloxacilina
- Orbenin
- Chloroxacillin
- Clossacillina
- Cloxacillinum
- MCIPC
- Syntarpen
- Tegopen
- Clossacillina [DCIT]
- Cloxacillin sodium
- BRL 1621
- Cloxacilina [INN-Spanish]
- Cloxacillin (INN)
- Cloxacillin [INN:BAN]
- Cloxacilline [INN-French]
- Cloxacillinum [INN-Latin]
- Cloxapen (TN)
- Cloxapen (sodium monohydrate)
- Methylchlorphenylisoxazoryl-penicillin
- Novo-Cloxin
- Nu-Cloxi
- Orbenin (TN)
- Tegopen (sodium monohydrate)
- BRL-1621 (sodium monohydrate)
- P-25 (sodium monohydrate)
- [3-(O-CHLOROPHENYL)-5-METHYL-4-ISOXAZOLYL]PENICILLIN
- (3-(o-Chlorophenyl)-5-methyl-4-isoxazolyl)penicillin
- oxacillin sodium monohydrate impurity e (ep impurity)
- O6X5QGC2VB
Look up CLOXACILLIN in the interactive SynDRA portal →